Chen, Meiwan
University of Macau,
Macao
2025 Rank: 73142
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nanoscience & Nanotechnology
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 2839 out of 156020 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 73142 | 78684 |
| Total Cites | 1879 | 1956 |
| H-index | 20 | 21 |
| Hm-index | 8 | 9 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 25 | 25 |
| Number of Single+First+Last Authored Papers | 91 | 91 |
| Total Cites to Single+First+Last Authored Papers | 667 | 685 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1754 | 1814 |
| Ratio of Total Citations to Distinct Citing Papers | 1.07 | 1.08 |
| Self-Citation Percentage |
3.94%
|
|
Chen, Meiwan
University of Macau,
Macao
2024 Rank: 74813
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nanoscience & Nanotechnology
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 2658 out of 135958 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 74813 | 80777 |
| Total Cites | 1628 | 1738 |
| H-index | 18 | 19 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 34 | 35 |
| Number of Single+First+Last Authored Papers | 88 | 88 |
| Total Cites to Single+First+Last Authored Papers | 541 | 568 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1538 | 1618 |
| Ratio of Total Citations to Distinct Citing Papers | 1.06 | 1.07 |
| Self-Citation Percentage |
6.33%
|
|
Chen, Meiwan
Institute of Chinese Medical Sciences,
Macao
2023 Rank: 86845
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nanoscience & Nanotechnology
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 2935 out of 117692 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 86845 | 98521 |
| Total Cites | 1425 | 1512 |
| H-index | 17 | 17 |
| Hm-index | 7 | 8 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 36 | 37 |
| Number of Single+First+Last Authored Papers | 78 | 78 |
| Total Cites to Single+First+Last Authored Papers | 478 | 506 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1323 | 1387 |
| Ratio of Total Citations to Distinct Citing Papers | 1.08 | 1.09 |
| Self-Citation Percentage |
5.75%
|
|
Chen, Meiwan
Institute of Chinese Medical Sciences,
China
2022 Rank: 77687
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nanoscience & Nanotechnology
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 2366 out of 103235 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 77687 | 90233 |
| Total Cites | 1380 | 1446 |
| H-index | 17 | 17 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 42 | 42 |
| Number of Single+First+Last Authored Papers | 68 | 68 |
| Total Cites to Single+First+Last Authored Papers | 485 | 509 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1253 | 1291 |
| Ratio of Total Citations to Distinct Citing Papers | 1.10 | 1.12 |
| Self-Citation Percentage |
4.56%
|
|
Chen, Meiwan
University of Macau,
China
2021 Rank: 83256
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nanoscience & Nanotechnology
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 2253 out of 89177 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 83256 | 92741 |
| Total Cites | 2083 | 2205 |
| H-index | 21 | 22 |
| Hm-index | 9 | 9 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 15 | 15 |
| Total Cites to Single+First Authored Papers | 54 | 55 |
| Number of Single+First+Last Authored Papers | 64 | 64 |
| Total Cites to Single+First+Last Authored Papers | 738 | 780 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1879 | 1952 |
| Ratio of Total Citations to Distinct Citing Papers | 1.11 | 1.13 |
| Self-Citation Percentage |
5.53%
|
|
Chen, Meiwan
Universidade de Macau,
Macao
2020 Rank: 71230
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nanoscience & Nanotechnology
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 1983 out of 75210 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 71230 | 79982 |
| Total Cites | 1573 | 1698 |
| H-index | 19 | 20 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 15 | 15 |
| Total Cites to Single+First Authored Papers | 48 | 48 |
| Number of Single+First+Last Authored Papers | 62 | 62 |
| Total Cites to Single+First+Last Authored Papers | 549 | 585 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1442 | 1511 |
| Ratio of Total Citations to Distinct Citing Papers | 1.09 | 1.12 |
| Self-Citation Percentage |
7.36%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.